Comparison between Combined regional nasal block and general anesthesia versus general anesthesia with dexmedetomidine during endoscopic sinus surgery
Phase 4
Recruiting
- Conditions
- Anaesthesia
- Registration Number
- PACTR202201855749323
- Lead Sponsor
- Faculty of medicine Ain shams university
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
Inclusion Criteria:
1) Patients of ASA I or ASA II physical status.
2) Patients with age 18-65 years.
Exclusion Criteria
Exclusion Criteria:
1) Patients with physical status ASA III, IV.
2) Known allergic reactions to local anesthetics.
3) Patients with history for cerebrovascular or coronary insufficiency.
4) Patients with infection at the block site.
5) Patients with coagulopathy.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie the analgesic effects of regional nasal block in endoscopic sinus surgery?
How does combined regional nasal block compare to dexmedetomidine in reducing perioperative opioid use during endoscopic sinus surgery?
Are there specific biomarkers that predict better outcomes with regional nasal block versus dexmedetomidine in sinonasal procedures?
What are the potential adverse events associated with regional nasal block techniques in ENT surgeries and how are they managed?
How does the use of alpha-2 adrenergic agonists like dexmedetomidine influence postoperative recovery profiles in endoscopic sinus surgery compared to regional blocks?